Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Single-arm, Open-label Phase II Efficacy Study of First-in-class HIF2-Alpha Inhibitor, PT2385, for Patients with Recurrent Glioblastoma
Grant
Overview
Affiliation
Overview
Awarded By
Johns Hopkins University
Total Award Amount
21000.00
Direct Costs
10815.00
Sponsor Award Id
ABTC1602
Affiliation
Contributor
Hassan Fathallah-Shaykh M.D., Ph.D.
Investigator
Louis Nabors M.D.
Principal Investigator
Xiaosi Han
Investigator